Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

Abstract

PURPOSE Evidence supporting the clinical utility of predictive biomarkers of anthracycline activity is weak, with a recent meta-analysis failing to provide strong evidence for either HER2 or TOP2A. Having previously shown that duplication of chromosome 17 pericentromeric alpha satellite as measured with a centromere enumeration probe (CEP17) predicted… (More)
DOI: 10.1200/JCO.2013.54.7869

5 Figures and Tables

Topics

Statistics

0501002015201620172018
Citations per Year

104 Citations

Semantic Scholar estimates that this publication has 104 citations based on the available data.

See our FAQ for additional information.

  • Presentations referencing similar topics